Detection and Grading of Endolymphatic Hydrops in Menière Disease Using MR Imaging

References

1. 1.↵
   Committee on Hearing and Equilibrium. Meniere's disease: criteria for diagnosis and evaluation of therapy for reporting. AAO-HNS Bulletin 1985;5:6–7
2. 2.↵
   Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Menière's disease: American Academy of Otolaryngology-Head and Neck Foundation, Inc. Otolaryngol Head Neck Surg 1995;113:181–85

   FREE Full Text
3. 3.↵
   1. Greco A,
   2. Gallo A,
   3. Fusconi M,
   4. et al

   . Meniere's disease might be an autoimmune condition? Autoimmun Rev 2012;11:731–38

   CrossRefPubMed
4. 4.↵
   1. Lawrence M,
   2. McCabe BF

   . Inner-ear mechanics and deafness: special consideration of Meniere's syndrome. J Am Med Assoc 1959;171:1927–32

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Gates P

   . Hypothesis: could Meniere's disease be a channelopathy? Intern Med J 2005;35:488–89

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Belal A Jr.,
   2. Antunez JC

   . Pathology of endolymphatic hydrops. J Laryngol Otol 1980;94:1231–40

   CrossRefPubMed
7. 7.↵
   1. Rauch SD,
   2. Merchant SN,
   3. Thedinger BA

   . Meniere's syndrome and endolymphatic hydrops: double-blind temporal bone study. Ann Otol Rhinol Laryngol 1989;98:873–83

   Abstract/FREE Full Text
8. 8.↵
   1. Merchant SN,
   2. Adams JC,
   3. Nadol JB Jr.

   . Pathophysiology of Meniere's syndrome: are symptoms caused by endolymphatic hydrops? Otol Neurotol 2005;26:74–81

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Berggren S

   . Histological investigation of three cases with Menière's syndrome. Arch Otolaryngol 1949;37:30
10. 10.↵
    1. Arnvig J

    . Histological findings in a case of Menière's disease, with remarks on the pathologic-anatomical basis of this lesion. Acta Oto-laryngol 1947;35:453–66

    CrossRef
11. 11.↵
    1. Belal A Jr.,
    2. Ylikoski J

    . Pathologic significance of Meniere's symptom complex: a histopathologic and electron microscopic study. Am J Otolaryngol 1980;1:275–84

    CrossRefPubMed
12. 12.↵
    1. Fraysse BG,
    2. Alonso A,
    3. House WF

    . Menière's disease and endolymphatic hydrops: clinical-histopathological correlations. Ann Otol Rhinol Laryngol Suppl 1980;89(6 pt 3):2–22

    PubMed
13. 13.↵
    1. Naganawa S,
    2. Ishihara S,
    3. Iwano S,
    4. et al

    . Three-dimensional (3D) visualization of endolymphatic hydrops after intratympanic injection of Gd-DTPA: optimization of a 3D-real inversion-recovery turbo spin-echo (TSE) sequence and application of a 32-channel head coil at 3T. J Magn Reson Imaging 2010;31:210–14

    CrossRefPubMed
14. 14.↵
    1. Schuknecht HF

    . Pathology of the Ear. Cambridge, Massachusetts; Harvard University Press; 1974:88
15. 15.↵
    1. Niyazov DM,
    2. Andrews JC,
    3. Strelioff D,
    4. et al

    . Diagnosis of endolymphatic hydrops in vivo with magnetic resonance imaging. Otol Neurotol 2001;22:813–17

    CrossRefPubMed
16. 16.↵
    1. Nakashima T,
    2. Naganawa S,
    3. Sugiura M,
    4. et al

    . Visualization of endolymphatic hydrops in patients with Meniere's disease. Laryngoscope 2007;117:415–20

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Naganawa S,
    2. Yamazaki M,
    3. Kawai H,
    4. et al

    . Visualization of endolymphatic hydrops in Menière's disease with single-dose intravenous gadolinium-based contrast media using heavily T(2)-weighted 3D-FLAIR. Magn Reson Med Sci 2010;9:237–42

    CrossRefPubMed
18. 18.↵
    1. Tagaya M,
    2. Teranishi M,
    3. Naganawa S,
    4. et al

    . 3 Tesla magnetic resonance imaging obtained 4 hours after intravenous gadolinium injection in patients with sudden deafness. Acta Otolaryngol 2010;130:665–69

    CrossRefPubMed
19. 19.↵
    1. Naganawa S,
    2. Yamazaki M,
    3. Kawai H,
    4. et al

    . Imaging of Menière's disease after intravenous administration of single-dose gadodiamide: utility of subtraction images with different inversion time. Magn Reson Med Sci 2012;11:213–19

    CrossRefPubMed
20. 20.↵
    1. Suzuki H,
    2. Teranishi M,
    3. Sone M,
    4. et al

    . Contrast enhancement of the inner ear after intravenous administration of a standard or double dose of gadolinium contrast agents. Acta Otolaryngol 2011;131:1025–31

    CrossRefPubMed
21. 21.↵
    1. Sano R,
    2. Teranishi M,
    3. Yamazaki M,
    4. et al

    . Contrast enhancement of the inner ear in magnetic resonance images taken at 10 minutes or 4 hours after intravenous gadolinium injection. Acta Otolaryngol 2012;132:241–46

    CrossRefPubMed
22. 22.↵
    1. Fukuoka H,
    2. Tsukada K,
    3. Miyagawa M,
    4. et al

    . Semi-quantitative evaluation of endolymphatic hydrops by bilateral intratympanic gadolinium-based contrast agent (GBCA) administration with MRI for Meniere's disease. Acta Otolaryngol 2010;130:10–16

    CrossRefPubMed
23. 23.↵
    1. Naganawa S,
    2. Sugiura M,
    3. Kawamura M,
    4. et al

    . Imaging of endolymphatic and perilymphatic fluid at 3T after intratympanic administration of gadolinium-diethylene-triamine pentaacetic acid. AJNR Am J Neuroradiol 2008;29:724–26

    Abstract/FREE Full Text
24. 24.↵
    1. Tagaya M,
    2. Yamazaki M,
    3. Teranishi M,
    4. et al

    . Endolymphatic hydrops and blood-labyrinth barrier in Menière's disease. Acta Otolaryngol 2011;131:474–79

    CrossRefPubMed
25. 25.↵
    1. Carfrae MJ,
    2. Holtzman A,
    3. Eames F,
    4. et al

    . 3 Tesla delayed contrast magnetic resonance imaging evaluation of Menière's disease. Laryngoscope 2008;118:501–05

    CrossRefPubMed
26. 26.↵
    1. Fiorino F,
    2. Pizzini FB,
    3. Beltramello A,
    4. et al

    . Reliability of magnetic resonance imaging performed after intratympanic administration of gadolinium in the identification of endolymphatic hydrops in patients with Menière's disease. Otol Neurotol 2011;32:472–77

    CrossRefPubMed
27. 27.↵
    1. Silverstein H,
    2. Rowan PT,
    3. Olds MJ,
    4. et al

    . Inner ear perfusion and the role of round window patency. Am J Otol 1997;18:586–89

    PubMed
28. 28.↵
    1. Yamazaki M,
    2. Naganawa S,
    3. Tagaya M,
    4. et al

    . Comparison of contrast effect on the cochlear perilymph after intratympanic and intravenous gadolinium injection. AJNR Am J Neuroradiol 2012;33:773–78

    Abstract/FREE Full Text
29. 29.↵
    1. Hallpike CS,
    2. Cairns H

    . Observations on the pathology of Menière's syndrome. Proc R Soc Med 1938;31:1317–36

    PubMed
30. 30.↵
    1. Werner CF

    . Das Gehörorgan der Wirbeltiere und des Menschen. Beispiel für eine vergleichende Morphologie der Lagebeziehungen. Leipzig, Germany: Veb Georg Thieme; 1960:77–80
31. 31.↵
    1. Yamashita T,
    2. Schuknecht HF

    . Apical endolymphatic hydrops. Arch Otolaryngol 1982;108:463–66

    CrossRefPubMed
32. 32.↵
    1. Liu F,
    2. Huang W,
    3. Meng X,
    4. et al

    . Comparison of noninvasive evaluation of endolymphatic hydrops in Meniere's disease and endolymphatic space in healthy volunteers using magnetic resonance imaging. Acta Otolaryngol 2012;132:234–40

    CrossRefPubMed
33. 33.↵
    1. Sperling NM,
    2. Paparella MM,
    3. Yoon TH,
    4. et al

    . Symptomatic versus asymptomatic endolymphatic hydrops: a histopathologic comparison: review. Laryngoscope 1993;103:277–85

    PubMed
34. 34.↵
    1. Nakashima T,
    2. Naganawa S,
    3. Pyykko I,
    4. et al

    . Grading of endolymphatic hydrops using magnetic resonance imaging. Acta Otolaryngol Suppl 2009;560:5–8

    PubMed